Health & pharmaceuticals news
Latest breaking stories, features and analysis
This beaten down Cathie Wood stock is a ‘buy’: DA Davidson
- DA Davidson says Teladoc stock is a "buy" with upside to $45.
- The bullish note arrives even after the disappointing Q2 report.
- The Cathie Wood stock is down 60% versus the start of 2022.